# Phase 2 mouth cancer trials recruiting: 22 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 22 trials in phase 2 for mouth cancer that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Phase 2 mouth cancer trials: 22 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email.

Buy: https://specstream.ai/data/clinical-trials/recruiting/phase-2/mouth-neoplasms

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 22
- Recruiting or not yet: 22
- Read on: November 19, 2026

## Trials

The 22 newest of 22, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| April 8, 2026 | NCT07518485 | Prospective Clinical Study to Identify Secondary Sentinel Lymph Nodes in Patients With N1/N2b Oral Cavity or H&N Skin Cancers Using Patent... | Centre Hospitalier Universitaire Vaudois | Phase 2 | Not yet recruiting | N1/N2b Oral Cavity Cancer, Head and Neck Skin Cancer | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07518485) |
| February 10, 2026 | NCT07400094 | Neoadjuvant Chemoimmunotherapy (Camrelizumab + Paclitaxel + Carboplatin) for Resectable HNSCC | National Medical Research Radiological Centre of the Ministry of Health of Russia | Phase 2 | Not yet recruiting | Squamous Cell Carcinoma of Head and Neck, Laryngeal Neoplasms, Oral Cavity Neoplasm | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07400094) |
| November 28, 2025 | NCT07254962 | CApecitabine Prior to TUmor Resection in Ent Oncology (CAPTURE) | Sir Mortimer B. Davis - Jewish General Hospital | Phase 2 | Not yet recruiting | Head Neck Cancer, Mouth Cancer, Throat Cancer, Larynx Cancer, Skin Cancer Face | 75 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07254962) |
| October 6, 2025 | NCT07209189 | Neoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head and Neck Cancer Treatment De-escalation (NeoScorch... | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Phase 2 | Recruiting | Head and Neck Cancer, Squamous Cell Carcinoma, Oral Cavity Cancer, Oropharyngeal Cancer, Laryngeal Cancer, Sinonasal... | 75 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07209189) |
| September 29, 2025 | NCT07195734 | Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer | National Cancer Institute (NCI) | Phase 2 | Recruiting | Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage III HPV-Mediated... | 180 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07195734) |
| August 13, 2025 | NCT07121595 | Personalized Neck Radiation Therapy Directed by Sentinel Lymph Node Biopsy for the Treatment of Oral Cavity Squamous Cell Carcinoma... | University of Michigan Rogel Cancer Center | Phase 2 | Recruiting | Oral Cavity Squamous Cell Carcinoma, Stage I Lip and Oral Cavity Cancer AJCC v8, Stage II Lip and Oral Cavity Cancer... | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07121595) |
| July 14, 2025 | NCT07063212 | A Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Cancer (HNSCC) | Memorial Sloan Kettering Cancer Center | Phase 2 | Recruiting | Squamous Cell Carcinoma of Head and Neck, Sinus Cancer, Nasal Cavity Cancer, Oral Cavity Cancer, Oropharynx Cancer... | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07063212) |
| May 30, 2025 | NCT06997068 | Methotrexate, Erlotinib, and Celecoxib for the Treatment of Recurrent/Metastatic Head and Neck Cancer in a Rural Midwest United States... | Mayo Clinic | Phase 2 | Recruiting | Metastatic Oral Cavity Carcinoma, Recurrent Oral Cavity Carcinoma, Stage IVC Lip and Oral Cavity Cancer AJCC v8, Head... | 25 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06997068) |
| May 20, 2025 | NCT06980038 | Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With... | National Cancer Institute (NCI) | Phase 2 | Recruiting | Head and Neck Squamous Cell Carcinoma, Hypopharyngeal Squamous Cell Carcinoma, Laryngeal Squamous Cell Carcinoma, Nasal... | 44 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06980038) |
| March 14, 2025 | NCT06876038 | Low-cost Screening and Image-guided Photodynamic Therapy (PDT) of Premalignant and Malignant Oral Lesions | University of Massachusetts, Boston | Phase 2 | Not yet recruiting | Oral Cancer, Oral Cavity Cancer, Oral Leukoplakia, Oral Lichen Planus, Oral Squamous Cell Carcinoma | 65 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06876038) |
| February 27, 2025 | NCT06848439 | Benmelstobart-Anlotinib-Chemo for Neoadjuvant Oral Cancer | Jiangsu Cancer Institute & Hospital | Phase 2 | Not yet recruiting | Mouth Neoplasms, Neoadjuvant Therapy, Immunotherapy, Molecular Targeted Therapy | 26 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06848439) |
| October 15, 2024 | NCT06636734 | Lovastatin and Pembrolizumab for the Treatment of Patients With Recurrent or Metastatic Head and Neck Cancer, LAPP Trial | Emory University | Phase 2 | Recruiting | Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Human Papillomavirus-Related Neck... | 28 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06636734) |
| October 4, 2024 | NCT06627270 | Antibiotic Treatment Effects on Intratumoral Bacteria Modulation in Surgical Patients With Oral Cancer | Case Comprehensive Cancer Center | Phase 2 | Recruiting | Oral Squamous Cell Carcinoma, Oral Cancer, Head and Neck Cancer, Head and Neck Carcinoma | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06627270) |
| August 1, 2024 | NCT06532279 | Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and... | NRG Oncology | Phase 2 | Recruiting | Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage II HPV-Mediated... | 98 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06532279) |
| June 7, 2024 | NCT06448026 | Cemiplimab and Cetuximab Prior Salvage Surgery in Patients With Recurrent Oral Cavity and HPV-negative Oropharyngeal Squamous Cell Carcinoma | M.D. Anderson Cancer Center | Phase 2 | Recruiting | Locally Recurrent Oral Cavity Squamous Cell Carcinoma | 17 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06448026) |
| January 23, 2024 | NCT06219980 | SBRT Followed by Neoadjuvant Chemoimmunotherapy of Sindilizumab Plus Docetaxel and Cisplatin for Locoregionally Advanced Squamous Carcinoma... | Sun Yat-sen University | Phase 2 | Recruiting | SBRT | 25 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06219980) |
| November 14, 2023 | NCT06130332 | Neoadjuvant Tirellizumab Combined With Chemotherapy for Early Oral Squamous Cell Carcinoma(HNC-SYSU-004) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Phase 2 | Recruiting | Oral Cancer, PD-1 | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06130332) |
| August 8, 2023 | NCT05980702 | 4 Courses vs 2 Courses of Pembrolizumab Combined With Carboplatin and Albumin-binding Paclitaxel of Neoadjuvant Therapy in HNSCC | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Phase 2 | Recruiting | HNSCC, Oral Cancer, PD-1 | 192 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05980702) |
| July 12, 2023 | NCT05941338 | Tirelizumab in Combination With Carboplatin and Albumin-binding Paclitaxel for Neoadjuvant Therapy in HNSCC | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Phase 2 | Recruiting | Head and Neck Squamous Cell Carcinoma, Oral Cancer | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05941338) |
| November 29, 2021 | NCT05136196 | BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head... | National Cancer Institute (NCI) | Phase 2 | Recruiting | Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma... | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05136196) |
| April 12, 2016 | NCT02734537 | Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have... | ECOG-ACRIN Cancer Research Group | Phase 2 | Recruiting | Head and Neck Squamous Cell Carcinoma, Hypopharyngeal Squamous Cell Carcinoma, Laryngeal Squamous Cell Carcinoma... | 189 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02734537) |
| November 13, 2014 | NCT02290145 | Cyclin D1 Based TPF Induction Chemotherapy for Oral Squamous Cell Carcinoma Patients at Clinical N2 Stage | Shanghai Jiao Tong University School of Medicine | Phase 2 | Recruiting | Mouth Neoplasms, Carcinoma, Squamous Cell | 48 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02290145) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 3 |
| National Cancer Institute (NCI) | 3 |
| NRG Oncology | 1 |
| Jiangsu Cancer Institute & Hospital | 1 |
| Centre Hospitalier Universitaire Vaudois | 1 |
| Sun Yat-sen University | 1 |
| M.D. Anderson Cancer Center | 1 |
| Memorial Sloan Kettering Cancer Center | 1 |
| Sir Mortimer B. Davis - Jewish General Hospital | 1 |
| Shanghai Jiao Tong University School of Medicine | 1 |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 1 |
| University of Michigan Rogel Cancer Center | 1 |
| Case Comprehensive Cancer Center | 1 |
| ECOG-ACRIN Cancer Research Group | 1 |
| Mayo Clinic | 1 |
| National Medical Research Radiological Centre of the Ministry of Health of Russia | 1 |
| Emory University | 1 |
| University of Massachusetts, Boston | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 12 |
| China | 6 |
| Switzerland | 1 |
| Russia | 1 |
| India | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Dentistry schools in the United States](https://specstream.ai/data/businesses/dentistry-schools/united-states)
- [Masonry contractors in the United States](https://specstream.ai/data/businesses/masonry-contractors/united-states)
- [Test preparation centers in the United States](https://specstream.ai/data/businesses/test-preparation-centers/united-states)
- [Chiropractic clinics in the United States](https://specstream.ai/data/businesses/chiropractic-clinics/united-states)
- [IP and internet law firms in the United States](https://specstream.ai/data/businesses/ip-and-internet-law-firms/united-states)
- [Shoe factory manufacturers in the United States](https://specstream.ai/data/businesses/shoe-factory-manufacturers/united-states)
